Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This drop was anticipated as there's a gap just below .04 a few months back.
Thank you. I have preordered the device. I sure wish there was better communication.
I'm not sure but I think an actual device or 100, may need to be submitted for review and approval. If production didn't start till November that may be why they haven't submitted the form. I think another poster is keeping track to see if/when the company files the form.
Yes I saw that. Why would they have not completed that way ahead of time??
Did you see the post about the 514k FDA form that the company must file before the product can be sold? It has a minimum 90 day time period before it can be marketed, so the product launch based on this requirement seems a ways off. Have you heard differently..
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170429623
I hope your second paragraph is off but we are in crazy, cheating times.
It’s just tough to know how to approach this stock.
I’m still buying but it’s looking like November may come and go with no updates on production ….
It's really hard to tell if they're buys or sells. The trade tracker on ihub separates them but I bought shares before and they show up in the sell column and vice versa.
In all honesty I think the market is in melt down mode. The shorts rule everywhere in all markets. Keep hearing 2023, the new monetary cbdc crypto currency is coming out and it's the end of cash. Once cash is gone we will be slaves and zombies. When we don't do what we're told, they'll turn off our access to our money.
These relatively bigger transactions the past couple days sells/buys? Opinions on what’s going on? Thanks in advance.
Don't be surprised if APYP opens ANY DAY ABOVE $1.00+
so upward pressure being applied now...
Because they are a penny stock company and probably working on absolute thin margins
But why? They he haven't even filed the 510k which has to be done at least 90 days before release
Sleep technologies has become a lucrative industry and forecast to be worth US $7 billion (£6 billion) by 2026. Good new for the Tech companies. $APYP
https://wellcome.org/news/consumer-sleep-tracker-role-research-mental-health
North America sleep tech devices business captured over 42% market share in 2021 and is poised to grow substantially through 2030. Within 12 hours of going on Pre-sale, the DreamIt wristband sold out. $APYP is going strong and great stock to put in the watchlist
Please post the status of the 510k when it's filed. I called the FDA today to see where that filing status website would be, but it's closed today for the holiday.
You're welcome. Will be looking for that 510K
Thanks for that find. We got a ways to go........ I've always thought.
AppYea (OTCQB: APYP), Undervalued health-tech with Lucrative Growth Potential
https://10xalerts.com/appyea-otcqb-apyp-undervalued-health-tech-with-lucrative-growth-potential/
The FDA requires that companies submit a 510(k) at least 90 days before marketing the device.
Watch the video. $APYP
$APYP Appyea alert to 'huge' opportunities for its products to stop snoring and sleep apnea https://t.co/d9piWh6lKJ @AppYea #APYP
— Proactive USA (@proactive_NA) November 8, 2022
First Apple or Google buy out even though their tech is better and ALREADY on the market, now French Medicare. Lol
Link to french agreement please
French Medicare $APYP
Check out @Bobbertino message on StockTwits http://stocktwits.com/Bobbertino/message/495329663
Sleeping aids market is expected to see tremendous growth along with the increasing demand for smart products. The market growth can anticipate to create lucrative opportunities for the companies like $APYP, a top startup in Texas.
There is never a bad time for a good product. People need help sleeping whether the market is good or bad.
Considering the economic times we're in, do you think this is the best time to roll out a new product?
So far, this is the lamest roll out of a "real" product imaginable. If they want to make their company look like smoke and mirrors they are doing a great job and at the same time doing a total shit job. So obvious it's obnoxious.
$APYP new tweet of video interview about products… see video on YouTube below.
— AppySleep (OTCQB: APYP) (@SleepXclear) November 8, 2022
Look forward to good things but want to see more than a paid advertisement.
Appyea alert to 'huge' opportunities for its products to stop snoring and sleep apnea $APYP
https://www.proactiveinvestors.co.uk/companies/news/997701/appyea-alert-to-huge-opportunities-for-its-products-to-stop-snoring-and-sleep-apnea-997701.html
Look in the mirror and tell me what you see
Sweet Amazon Halo.
Maybe so, but whoever might have that interest will need to buy about 10-20, so they can do an evaluation to see if the product is worth a buyout offer.
Agree. Apple or Google Buyout. $APYP
I predict a Buyout $APYP
Apple and Google both want to make a copycat,
but we hold the patents.
Could be on the verge of something Rilly Rilly BIG ! Stay tuned and watch the fireworks.
There will be no uplist. It’s a $hit pink sheet ticker
See new Twitter today with video: $APYP Final tests before DreamIT mass production
$APYP
— AppySleep (OTCQB: APYP) (@SleepXclear) November 3, 2022
Final tests before DreamIT mass production pic.twitter.com/9OaaAV1SQX
New message on linkedin
New Tweet 11.02.22 $APYP
— AppySleep (OTCQB: APYP) (@SleepXclear) November 2, 2022
We can tell with that insightful DD.
Nice accumulation on this one. Run up will be legendary. $APYP https://sleepxapp.com/
There is no potential.
Me too. I'm thinking APYP has great potential.
I think so. After TSNP/HMBL it seemed like it dropped off significantly. Hoping it's cyclical and tuns back soon.
Followers
|
513
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
52604
|
Created
|
10/22/14
|
Type
|
Free
|
Moderators |
Working today for tomorrow's future.
The Diagnostic Center Inc, is a newly formed marketing and service subsidiary of AppYea, Inc. (OTC:APYP) that empowers physician offices, clinics, hospitals, long term care facilities, healthcare groups, employers, governmental units and correctional institutions in getting comprehensive diagnostic testing results quicker. Our goal is to work with multiple diagnostic testing facilities throughout the United States and at the same time using numerous collectors to handle the samples personally therefore expediting the process.
We provide fast and accurate results. With screening results within 24 hours and full confirmation of 78 tests.
https://www.thediagnosticcenters.com/investors/
Boca Raton, FL, and Rehovot, Israel (OTC Pink: APYP) AppYea, Inc. ("AppYea" or the "Company") begun the process to acquire 100% of the outstanding shares of SleepX Ltd., a company formed under the laws of Israel ("SleepX") and Nexense Technologies USA Inc., a Delaware corporation.
Todd Violette, CEO of AppYea stated, "I have been very impressed with the SleepX management team in Israel and SleepXs products and technology. SleepX holds a portfolio of patents and products designed to prevent snoring and sleep apnea, which I believe present a unique opportunity for AppYea."
AppYea management's review of information from Research and Markets September 18, 2020 industry report, indicates the global sleep apnea device market is forecast to increase to US$9.29 billion in 2024, growing at a compounded annual growth rate of 7.94% between 2020-2024. The same report found that the fastest-growing regional market wasNorth America, with the highest incidence of obstructive sleep apnea cases, provided that Europealso represents a large available market.
"SleepX has developed a unique technology for monitoring sleep apnea. The Technology and IP are protected via international patents - sleep apnea detection and sleep phases analysis through sound wave analysis, developed in the Biomedical Department of Ben Gurion University in Beer Sheva, Israel.Based on this technology, one of the leading products SleepX offers is a unique night bracelet for the treatment of snoring using artificial Intelligence", said Bary Molchadsky, CEO of SleepX.
News LINK: https://www.otcmarkets.com/stock/APYP/news/APYP-begin-process-for-Acquisition-of-SleepX-Ltd?id=287757
Boca Raton, FL (OTC Ticker: APYP) Appyea, Inc, on January 28, 2021, announced the entry into a non-binding Letter of Intent (LOI) for the acquisition of SleepX Ltd. from Israel.
https://www.otcmarkets.com/stock/APYP/news/APYP-Update?id=290348
Patent information
https://www.sleepxclear.com/unique-technology
*******************************************************************************************************************************************************************************************************************************************************************
AppYea Holding Inc.
Cannabis Blockchain
One of our subsidiaries, will be going into the Cannabis Blockchain Business. Last year, while I was researching the cannabis industry, I identified some key business models unique to the cannabis industry that are incredibly different from those currently being promoted in the Cannabis Capital Markets. The number one principle that drives the success in the cannabis industry for long term valuation and growth is the principle to acquire the "Customer First." Therefore, building a Cannabis Blockchain for the customers and expanding delivery services that deliver cannabis to people in their homes will be the end target market. I have approved the Subsidiary of AppYea Holding Inc., and the newly formed Canadian Subsidiary will transition, focusing the business development during 2021 on building a Cannabis Blockchain Company.
I view this opportunity based upon the belief that by 2022, California's cannabis market is projected to jump to $5 billion boosted significantly by California's recreational cannabis market. The California cannabis industry's total economic impact could be nearly $10 billion.
The Environmental benefit results from creating a decentralized, encrypted database validating SOP processes as they occur during Cannabis Cultivation. The record's benefit will track the amount of pesticide used, water consumed, and soil degradation.
The Person partaking in the use of the product benefits from a cleaner and better product to enjoy. In the future, we envision the consumer being able to scan the QR code with their phone and use the Blockchain to see the record of the nutrients solution recipe or the amount of pesticide used during the cultivation and packaging process. The end customer will have a history of the Cannabis plant through all stages of the plant's life cycle to verify the final product's product outcome and authenticity.
The Government could begin using the system to be more efficient with tax collections and implementing more effective regulatory policies. We can expect that governments will finally acceptblockchainbenefits and improve critical applications improving tracking financial transactions and ensuring people's identity in the seed to the sale process.
The Cannabis Blockchain cansignificantlyimprove supply chainsby enabling faster and more cost-efficient product deliveries, enhancing product traceability,and enhancingcoordination between customers, drivers, and central locations.
I feel these targeted areas with a combination of proprietary plans will allow the Company to build out a revenue model and use the base assets being developed to potentially generate revenue within the next year. I recently traveled to the Province of Saskatchewan to view a location and meet with a local representative that owns the property for a site that could access power, internet, and host multiple servers. The vision would include developing Agricultural Data and becoming an Ag Tech Datacenter using blockchain technology.
*******************************************************************************************************************************************************************************************************************************************************************
Mr. Todd Violette serves as NEW Chairman of the Board, Chief Executive Officer of the Company. Mr. Violette brings a wealth of experience to AppYea, having spent more than 24 years evaluating and participating investment opportunities across the capital structure of North American companies with a focus on OTC companies. Mr. Violette has worked in a management capacity as a chief executive officer, affecting corporate actions and implementing policies in order to maximize shareholder value. AppYea has previously announced its participation and desire to be in the CBD and Hemp business Mr. Violette disclosed to the Board a potential conflict of interest regarding his outside participation in a project working with a team of experts building 55,000 sq. feet private hemp exaction facility in in Western Kentucky. Any opportunity resulting from this operation will first be brought to AppYea. Mr. Violette graduated of the University of Maryland College Park in 1992.
*******************************************************************************************************************************************************************************************************************************************************************
Contact Information
AppYea Inc.
1-800-674-3561 or Email info@appyea.com
1-800-674-3561 Please Phone or Text Email: info@appyea.com
Twitter Link: https://twitter.com/AppyeaInc/status/1346914866183892994
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |